Lithium Shows Promise in Suppressing HIV Reactivation Through Novel Mechanism
核心洞察
McGill University researchers discovered that lithium, a widely used bipolar disorder (搜索) medication, can prevent HIV (搜索)-infected cells from reactivating in laboratory studies.
The study challenges previous assumptions by demonstrating that lithium's HIV (搜索) suppression effects persist even when autophagy (搜索) pathways are disrupted, suggesting alternative mechanisms are involved.
While promising for HIV (搜索) functional cure research, lithium has not been tested in humans as an HIV treatment and carries significant side effects that prevent immediate clinical application.
McGill University researchers have discovered that lithium, a medication commonly prescribed for bipolar disorder (搜索), demonstrates the ability to suppress HIV (搜索) reactivation in laboratory-grown human cells through an unexpected biological mechanism. The findings, published in iScience, offer new insights into potential pathways for achieving a functional HIV cure.
The study represents a significant development in HIV (搜索) cure research, which seeks to keep the virus dormant rather than eliminating it entirely. An estimated 40.8 million people worldwide were living with HIV in 2024, and even with effective antiretroviral therapy, the virus can remain hidden in immune cells and rebound if daily treatment stops.
Novel Mechanism Challenges Previous Assumptions
"In our experiments, lithium directly suppressed HIV (搜索) reactivation in lab-grown human cells, something that had not been clearly demonstrated before," said first author Ana-Luiza Abdalla, who conducted the work as a PhD student at McGill and is now a postdoctoral fellow at the Montreal Neurological Institute.
The research team made a surprising discovery about lithium's mechanism of action. Earlier research suggested lithium might work by activating autophagy (搜索), the cell's recycling system, leading scientists to assume this pathway was responsible for keeping the virus dormant. However, the new study challenges this assumption using a fluorescence-based test developed by University of Manitoba researcher Thomas Murooka that allows scientists to distinguish between dormant and active virus in cells.
"What surprised us was that the effect persisted even when we disrupted autophagy (搜索)," Abdalla explained. "That suggests other pathways are involved, possibly ones HIV (搜索) relies on to restart."
Drug Repurposing Strategy
Senior author Andrew Mouland, Professor in McGill's Department of Medicine and Head of the HIV (搜索)-1 RNA Trafficking Laboratory at the Lady Davis Institute for Medical Research, emphasized the strategic importance of investigating existing medications. "One major thrust in HIV cure research is asking whether existing drugs can be repurposed. Because lithium is inexpensive and already approved for other uses, it offers a faster starting point than developing a new drug from scratch."
The findings point toward future treatments designed to mimic lithium's beneficial effects while avoiding its broader impacts on the body. However, Mouland cautioned that the results do not mean people with HIV (搜索) should take lithium, as the psychoactive drug can cause significant side effects and has not yet been tested in humans as an HIV treatment.
Implications for Functional Cure Research
A functional cure aims to overcome the challenge of HIV (搜索)'s ability to remain hidden in immune cells by keeping the virus dormant so it cannot restart infection, potentially reducing the need for continuous daily medication. The discovery of lithium's HIV suppression capabilities through non-autophagy (搜索) pathways opens new avenues for understanding how to achieve sustained viral dormancy.
The research contributes to a growing body of work exploring combination approaches to HIV (搜索) cure strategies. The identification of alternative biological pathways involved in viral reactivation could inform the development of more targeted therapies that achieve lithium's beneficial effects without its associated side effects.